Using stable expression of shRNA constructs, we were able to reduce PINK1 gene expression by >90% in (1) a human dopaminergic neuroblastoma cell line (SH-SY5Y), and (2) human neurons derived from fetal mesencephalic stem cells that represent the closest in vitro model of primary human neurons. Here, PINK1 is linked to neuroblastoma.